ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by University Hospital, Brest
Sponsor:
Collaborators:
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT01848639
First received: May 3, 2013
Last updated: November 29, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2022
  Estimated Primary Completion Date: June 2021 (Final data collection date for primary outcome measure)